SGLT2 inhibitors could protect against dementia and Parkinson’s

SGLT2 inhibitors could protect against dementia and Parkinson’s

0 Comments

medicine

Monday, 23 September 2024

Seoul – Treatment with an SGLT2 inhibitor could protect patients with type 2 diabetes from degenerative brain diseases. This emerged in a population-based cohort study from South Korea, which has now been published in Neurology (2024; DOI: 10.1212/WNL.0000000000209805). Type 2 diabetes is a known risk factor for neurodegenerative diseases. A treatment that normalizes blood sugar could therefore be a…

#SGLT2 #inhibitors #protect #dementia #Parkinsons

Leave a Reply

Related Posts